HAVCR1 and hypertensive disorder: Sympercent change in KIM-1 from pre- to post-EV infusion was higher in participants with versus without HTN at 3 months post-cisplatin (increased pre- to post-EV by 58.22 pg/mg creatinine in patients with 3-month HTN; decreased by 28.28 pg/mg creatinine in patients without HTN; P < 0.05; Table 3).